For example, inhibitor OPB-51602 is showing promising effects against non-small cell lung carcinoma [172], and the STAT3 inhibitor napabucasin was shown to reduce both expression of stemness-related genes and sphere formation by glioblastoma cells [173]. Here, STAT3 is linked to glioblastoma.